TrialCancer immunology research2026
Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance).
Alvin Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.